Objective: To determine the effect of maternal cocaine exposure on fet
al lung maturity as measured by surfactant-albumin ratios determined b
y the TDx-FLM test. Methods: A case-control study design was used to c
ompare fetal lung maturity as assessed by a surfactant-albumin ratio a
ssay (TDx-FLM) in amniotic fluid (AF) obtained from women who were kno
wn to use cocaine and those who were not known to use cocaine during t
he study pregnancy. Multiple logistic regression procedures were used
to control for gestational age and possible confounders, such as obste
tric and nonobstetric complications, other substance abuse, race, infa
nt sex, and payer status. Results: Maternal cocaine use during pregnan
cy was associated with an accelerated fetal lung maturity profile (adj
usted odds ratio [OR] 2.04, 95% confidence interval [CI] 1.04-4.00) as
determined by the TDx-FLM test. Other variables found to be statistic
ally significant predictors of a mature fetal lung profile were cigare
tte smoking during the current pregnancy (OR 1.61, 95% CI 1.02-2.56).
Preterm labor, preterm rupture of membranes, nonobstetric illness duri
ng pregnancy, and exposure to other abused substances were not associa
ted with accelerated fetal lung maturity. Conclusion: Maternal cocaine
use during pregnancy is associated with a doubling of the probability
of a mature fetal lung profile as determined by TDx-FLM analysis of A
F. Tobacco use is also a predictor of accelerated fetal lung maturity
profiles.